Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacteriostatic sodium chloride is a sterile, nonpyrogenic, isotonic solution of 0.9% sodium chloride (NaCl) in water for injection with benzyl alcohol (0.9% or 9 mg/mL) added as a preservative[1][2][4][8]. It is primarily used as a diluent for parenteral drugs that require dissolution or dilution before intravenous administration and as a flush for intravascular catheters[2][4]. The presence of benzyl alcohol inhibits bacterial growth in the solution and allows repeated withdrawals from multi-dose vials[1][2]. Bacteriostatic saline also has mild local anesthetic properties due to benzyl alcohol[4]. It is not intended for use in newborns due to the risk of toxicity from benzyl alcohol. Sodium and chloride ions provided by this solution are essential electrolytes involved in maintaining fluid and electrolyte balance within the body[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bacteriostatic sodium chloride.